HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Heitmiller, R. F. Articles by Sharma, R. R. Search for Related Content PubMed PubMed Citation Articles by Heitmiller, R. F. Articles by Sharma, R. R.

J Thorac Cardiovasc Surg 1996;112:130-136
© 1996 Mosby, Inc.

GENERAL THORACIC SURGERY

COMPARISON OF PREVALENCE AND RESECTION RATES IN PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA AND ADENOCARCINOMA

Supported by the Evelyn Glick Fund for Thoracic Surgery.

Received for publication May 9, 1995 Accepted for publication Aug. 30, 1995. Address for reprints: Richard Heitmiller, MD, The Johns Hopkins Hospital, 600 N. Wolfe St., Osler 624, Baltimore, MD 21287-5674.

Abstract

Since 1987 we have observed a predominance of adenocarcinoma in patients undergoing esophagectomy because of carcinoma at our institution. To discover whether this observation represented an actual change in the prevalence of adenocarcinoma, the Johns Hopkins Hospital pathology records were reviewed for the years 1959 to 1994. Overall, esophageal squamous cell carcinoma was the most common histologic type with 817 cases identified versus 284 cases of adenocarcinoma. The number of patients with squamous cell carcinoma rose slowly from 1959 to 1992 but since 1992 has decreased. Whereas adenocarcinoma was uncommon before 1978, its frequency has since increased markedly, exceeding that of squamous cell carcinoma in 1994. The number of patients with adenocarcinoma who underwent surgical resection has equaled or exceeded the number of those treated nonoperatively for all recorded years. Therefore the predominance of adenocarcinoma in patients undergoing esophageal resection for carcinoma appears to result from two factors: an overall increase in the prevalence of adenocarcinoma since 1978 and an increased likelihood of resection for patients with these tumors. (J THORACCARDIOVASCSURG1996;112:130-6)

This article has been cited by other articles:

				M. Tachibana, S. Kinugasa, N. Hirahara, and H. Yoshimura Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 427 - 431. [Abstract] [Full Text] [PDF]

				M. Tachibana, N. Hirahara, S. Kinugasa, and H. Yoshimura Clinicopathologic Features of Superficial Esophageal Cancer: Results of Consecutive 100 Patients Ann. Surg. Oncol., January 1, 2008; 15(1): 104 - 116. [Abstract] [Full Text] [PDF]

				J. C. Bendell Latest Data on the Treatment of Upper Gastrointestinal Cancers ASCO Educational Book, January 1, 2008; 2008(1): 184 - 190. [Abstract] [Full Text] [PDF]

				J. R. Kroep, H. M. Pinedo, G. Giaccone, A. Van Bochove, G. J. Peters, and C. J. Van Groeningen Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer Ann. Onc., February 1, 2004; 15(2): 230 - 235. [Abstract] [Full Text] [PDF]

				M. Tachibana, S. Kinugasa, H. Yoshimura, D. K. Dhar, and N. Nagasue Extended Esophagectomy With 3-Field Lymph Node Dissection for Esophageal Cancer Arch Surg, December 1, 2003; 138(12): 1383 - 1389. [Abstract] [Full Text] [PDF]

				T.-T. Wu, T. Watanabe, R. Heitmiller, M. Zahurak, A. A. Forastiere, and S. R. Hamilton Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region Am. J. Pathol., July 1, 1998; 153(1): 287 - 294. [Abstract] [Full Text] [PDF]